Meta Platforms
META
Tesla
TSLA
Alphabet-A
GOOGL
Alphabet-C
GOOG
Taylor Morrison Home
TMHC
US Stock MarketDetailed Quotes
NKTR Nektar Therapeutics
- 0.9005
- -0.0278-2.99%
Close Dec 23 16:00 ET
- 0.9005
- 0.00000.00%
Post 16:54 ET
166.10MMarket Cap-1.07P/E (TTM)
0.9283High0.8701Low1.71MVolume0.9283Open0.9283Pre Close1.54MTurnover1.03%Turnover RatioLossP/E (Static)184.46MShares1.928052wk High3.40P/B149.23MFloat Cap0.480052wk Low--Dividend TTM165.72MShs Float111.3600Historical High--Div YieldTTM6.27%Amplitude0.4126Historical Low0.9010Avg Price1Lot Size
Nektar Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -4.30%-43.93M | 26.82%-37.7M | 7.76%-47.89M | 36.64%-192.61M | 18.47%-47.05M | 49.18%-42.12M | 31.30%-51.52M | 41.29%-51.92M | 26.33%-304.01M | 61.92%-57.7M |
| Net income from continuing operations | 19.15%-37.06M | -2.43%-52.36M | 73.14%-36.8M | 25.03%-276.06M | 29.50%-42.08M | 22.37%-45.84M | 67.86%-51.12M | -51.58%-137.02M | 29.71%-368.2M | 59.02%-59.69M |
| Operating gains losses | ---- | ---- | ---- | 117.41%6.4M | ---- | ---- | ---- | ---- | -558.10%-36.75M | -968.41%-3.33M |
| Depreciation and amortization | -41.42%993K | -32.64%1.46M | -30.19%1.61M | -40.02%7.82M | -48.08%1.65M | -36.68%1.7M | -37.05%2.17M | -38.28%2.3M | -7.89%13.03M | -7.39%3.18M |
| Deferred tax | -106.67%-31K | 311.11%57K | 97.90%-38K | -105.17%-140K | -36.71%1.71M | ---15K | ---27K | ---1.81M | 2,754.90%2.71M | --2.71M |
| Other non cash items | 20.77%-9.71M | -11.72%-7.32M | 4.01%-13.04M | -21.30%-43.59M | -7.37%-11.19M | -1.39%-12.26M | 31.85%-6.55M | -257.03%-13.59M | -436.44%-35.93M | -180.28%-10.43M |
| Change In working capital | 133.83%1.09M | 215.42%10.8M | -167.62%-6.62M | -4,124.39%-19.8M | 41.35%-4.73M | 88.36%-3.23M | -142.89%-9.36M | -117.05%-2.47M | 102.14%492K | 84.40%-8.07M |
| -Change in receivables | 2.19%-850K | 45.84%2.42M | -180.78%-2.41M | -71.07%4.78M | -82.00%999K | 43.05%-869K | -91.79%1.66M | 138.64%2.99M | 33.19%16.51M | 121.86%5.55M |
| -Change in inventory | -94.80%123K | 128.12%212K | 42.42%-1.14M | 120.55%699K | 838.62%1.07M | 213.36%2.37M | 52.58%-754K | -570.38%-1.99M | -568.17%-3.4M | 69.21%-145K |
| -Change in payables and accrued expense | 716.19%8.82M | 162.14%6.62M | 111.92%868K | -18.78%-20.01M | 77.82%-3.16M | 105.85%1.08M | -742.25%-10.65M | -142.41%-7.28M | 51.34%-16.84M | 54.61%-14.26M |
| -Change in other current assets | -3.65%-3.58M | 20.86%2.79M | -117.46%-976K | -48.12%3.58M | -142.40%-867K | -24.80%-3.45M | -51.48%2.31M | 95.22%5.59M | 367.05%6.91M | 160.15%2.05M |
| -Change in other working capital | -45.02%-3.42M | 35.89%-1.24M | -65.62%-2.96M | -230.22%-8.85M | -120.53%-2.77M | 18.84%-2.36M | -541.53%-1.93M | -199.94%-1.79M | -214.53%-2.68M | 93.36%-1.26M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -4.30%-43.93M | 26.82%-37.7M | 7.76%-47.89M | 36.64%-192.61M | 18.47%-47.05M | 49.18%-42.12M | 31.30%-51.52M | 41.29%-51.92M | 26.33%-304.01M | 61.92%-57.7M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -18.25%46.12M | -32.53%16.98M | -52.56%19.26M | -61.85%139.56M | -56.56%17.38M | -49.36%56.41M | -70.09%25.17M | -68.84%40.6M | 80.41%365.84M | -66.71%40.01M |
| Net PPE purchase and sale | -154.95%-666K | -14.81%-186K | 63.74%-157K | -94.95%380K | -101.87%-237K | 769.61%1.21M | 79.23%-162K | 89.70%-433K | 150.17%7.52M | 315.13%12.68M |
| Net investment purchase and sale | -15.25%46.78M | -32.23%17.17M | -52.68%19.42M | -61.16%139.18M | -35.53%17.62M | -50.53%55.2M | -70.17%25.33M | -69.49%41.03M | 64.54%358.32M | -78.33%27.33M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -18.25%46.12M | -32.53%16.98M | -52.56%19.26M | -61.85%139.56M | -56.56%17.38M | -49.36%56.41M | -70.09%25.17M | -68.84%40.6M | 80.41%365.84M | -66.71%40.01M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 13K | 5.56%19K | 42M | -98.01%30K | -88.35%12K | 0 | -96.15%18K | 0 | -95.84%1.51M | -95.96%103K |
| Net common stock issuance | --0 | --0 | ---3M | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Proceeds from stock option exercised by employees | --13K | 5.56%19K | --30M | -96.04%30K | -88.35%12K | --0 | -96.15%18K | --0 | -97.72%758K | -94.28%103K |
| Net other financing activities | --0 | --0 | --15M | ---- | ---- | ---- | ---- | ---- | -75.00%750K | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --13K | 5.56%19K | --42M | -98.01%30K | -88.35%12K | --0 | -96.15%18K | --0 | -95.84%1.51M | -95.96%103K |
| Net cash flow | ||||||||||
| Beginning cash position | -44.92%27.94M | -36.79%48.64M | -60.02%35.28M | 249.86%88.23M | -38.61%64.92M | -34.58%50.73M | 13.18%76.96M | 249.86%88.23M | -87.32%25.22M | 95.79%105.76M |
| Current changes in cash | -84.63%2.2M | 21.39%-20.7M | 218.17%13.37M | -183.70%-53.01M | -68.61%-29.65M | -49.87%14.29M | -373.69%-26.33M | -126.45%-11.32M | 136.47%63.34M | 38.91%-17.59M |
| Effect of exchange rate changes | 71.43%-28K | -100.93%-1K | -117.78%-8K | 118.96%62K | -85.45%8K | 66.78%-98K | 252.86%107K | 364.71%45K | -255.43%-327K | 650.00%55K |
| End cash Position | -53.62%30.11M | -44.92%27.94M | -36.79%48.64M | -60.02%35.28M | -60.02%35.28M | -38.61%64.92M | -34.58%50.73M | 13.18%76.96M | 249.86%88.23M | 249.86%88.23M |
| Free cash flow | -5.80%-44.6M | 26.69%-37.89M | 8.22%-48.05M | 37.53%-193.47M | 18.78%-47.28M | 49.25%-42.15M | 31.79%-51.69M | 43.49%-52.35M | 27.58%-309.68M | 63.02%-58.22M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.